Loading
Latest filing published 19 Mar 2021 for Sio Gene Therapies Inc..
No signal scores available.
Gavin Corcoran is a declared insider of Sio Gene Therapies Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 12 June 2020 to 17 March 2021.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 19 March 2021 came the latest disclosure, a share grant in Sio Gene Therapies Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations